June 27 (Reuters) - Vigil Neuroscience Inc VIGL.O :
* VIGIL NEUROSCIENCE ANNOUNCES $40 MILLION STRATEGIC
INVESTMENT
FROM SANOFI
* VIGIL NEUROSCIENCE INC - COMPANY EXPECTS PROCEEDS TO
EXTEND CASH
RUNWAY INTO 2026
* VIGIL NEUROSCIENCE INC - $40 MILLION STRATEGIC INVESTMENT
IN
COMPANY AT AN AS-CONVERTED PRICE OF $7.44 PER SHARE OF COMMON
STOCK
* VIGIL NEUROSCIENCE INC - SANOFI TO RECEIVE AN EXCLUSIVE
RIGHT OF
FIRST NEGOTIATION FOR LICENSE OF COMPANY'S SMALL MOLECULE TREM2
AGONIST PROGRAM
Source text for Eikon: ID:nGNX3WQhDz
Further company coverage: VIGL.O
((Reuters.Briefs@thomsonreuters.com;))